PK and PD of YG1699 in CKD Patients With Diabetes
NCT06648876
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Diabetes
Renal Insufficiency, Chronic
Hemodialysis
Interventions
DRUG:
YG1699
DRUG:
Placebo
Sponsor
RenJi Hospital